Emtricitabine Recruiting Phase 4 Trials for Human Immunodeficiency Virus Type 1 (HIV-1) Infection Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT04040075Testing the Safety and Efficacy of Commercial Drug Biktarvy in Subjects Known to Have the 184 Resistance Mutation to a Component in Biktarvy
NCT03532425B/F/TAF vs Atripla Double-Blind Switch Study in HIV-1 Infected Adults
NCT04225325Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).